Parekh Madhavi, Abrams Darryl, Brodie Daniel, Yip Natalie H
Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center, New York, New York.
Respir Care. 2018 Sep;63(9):1180-1188. doi: 10.4187/respcare.06262.
The use of extracorporeal membrane oxygenation in the management of ARDS has grown considerably in the past decade, largely as a consequence of improvements in extracorporeal technology and management techniques. Recently published data has helped clarify the use of ECMO in ARDS, and its role in optimizing lung-protective ventilation and minimizing ventilator-induced lung injury has the potential to have a substantial impact on ARDS management and outcomes. In the future, novel extracorporeal management strategies may lead to a new paradigm in our approach to patients with ARDS.
在过去十年中,体外膜肺氧合技术在急性呼吸窘迫综合征(ARDS)治疗中的应用显著增加,这主要得益于体外技术和管理技术的改进。最近公布的数据有助于明确体外膜肺氧合(ECMO)在ARDS治疗中的应用,其在优化肺保护性通气和减少呼吸机诱发的肺损伤方面的作用,有可能对ARDS的治疗和预后产生重大影响。未来,新型体外管理策略可能会引领我们对ARDS患者的治疗进入一个新的模式。